Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00285-5/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsmi=276617825&_hsenc=p2ANqtz-_JAiLxnWNRt4V7Xn568FCuWyoCtytyXFmunZoTvBnMxnvOGfG5CivhFnetqA0Zlx8qrKgq0GSRTg8ogtDWmMQZJtamDg&utm_content=275967893&utm_source=hs_email